Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Ivashko-Pachima et al
Based on Lilly's precedent with tirzepatide, retatrutide will likely receive separate brand names for different indications: Tirzepatide became Mounjaro for type 2 diabetes and Zepbound for obesity Retatrutide is expected to follow the same pattern with distinct brand names per indication Brand names are typically announced closer to the FDA approval date or during the NDA review period
J., Chung, C
Researchers may misinterpret this as high inter-subject variability or weak efficacy when the real cause is compromised sample integrity
US$ 20.72
US$ 28.63
US$ 24.56
US$ 24.82
US$ 25.80
